Skip to main content

ESPEROCT

NDC 0169-8400 · Novo Nordisk

Generic nameantihemophilic factor (recombinant), glycopegylated-exei
Dosage formKIT
Marketing categoryBLA

Packages

0169-8400-01 — 1 KIT in 1 KIT (0169-8400-01) * 4 mL in 1 VIAL, GLASS (0169-8401-11) * 4 mL in 1 SYRINGE, GLASS (0169-8008-98)

Billed under HCPCS

J7204 — Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu Medicare Part B payment limit (ASP + 6%): $2.30

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels